Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Noteable....if you had to guess?

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon Aug 19, 2021 11:09am

129 Views

Post# 33730243

RE:RE:Noteable....if you had to guess?

Should read: - [ Harry, further to your question on the Yahoo message board today, the below referenced response by 'dreamer' is the kind of contrived nonsense that is replete with as much self-serving negtivity that these posters can "dream" up and what you can expect from those whose ulterior motives are counter to the direction of the clinical development and ultimate success of the company ...]

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia